Daniel Gaudet

36k citations
469 papers · 28.9k · 38 hit papers · h-index 81

Impact in

Papers in

Daniel Gaudet

446 papers receiving 27.7k citations

Daniel Gaudet's Hit Papers

Familial chylomicronemia syndrome: An expert clinical review from the National Lipid Association 2025 · 28 citations
280+1+2Years since publication50100150200

Peers

Daniel Gaudet
Comparison fields: 5 of 162
  • Surgery 11.7k
  • Cardiology and Cardiovascular Medicine 5.5k
  • Endocrinology, Diabetes and Metabolism 3k
  • Genetics 4.2k
  • Molecular Biology 3.3k
Replace François Mach with:
François Mach Switzerland
Chris J. Packard United Kingdom
G. Kees Hovingh Netherlands
Anne Tybjærg‐Hansen Denmark
Peter Sever United Kingdom
Manjinder Singh Sandhu United Kingdom
Hubert Scharnagl Austria
Marju Orho‐Melander Sweden
Lena M. S. Carlsson Sweden
Christian Berne Sweden
Daniel Gaudet relative to François Mach Switzerland François Mach's profile →
Citations per field
00.5×2×2.6×
François Mach · 1×
Citations per year

Countries citing papers authored by Daniel Gaudet

Since Specialization
Citations

This map shows the geographic impact of Daniel Gaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Gaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Gaudet more than expected).

Fields of papers citing papers by Daniel Gaudet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Gaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Gaudet. The network helps show where Daniel Gaudet may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Gaudet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Gaudet Line = papers co-authored together Daniel Gaudet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 469 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Hit paper breakdown →
20001453
2
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Hit paper breakdown →
20181445
3
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Hit paper breakdown →
2008995
4
Hypertriglyceridemic Waist
Hit paper breakdown →
2000784
5
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2010780
6
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Hit paper breakdown →
2021655
7
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
Hit paper breakdown →
2001653
8
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2014644
9
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
Hit paper breakdown →
2012610
10
Evinacumab for Homozygous Familial Hypercholesterolemia
Hit paper breakdown →
2020607
11
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
Hit paper breakdown →
2019508
12
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Hit paper breakdown →
2012501
13 2008465
14
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Hit paper breakdown →
2015452
15
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Hit paper breakdown →
2022435
16
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Hit paper breakdown →
2014424
17 2002390
18
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Hit paper breakdown →
2019346
19 2012340
20
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Hit paper breakdown →
2017277

About Daniel Gaudet

Daniel Gaudet is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Genetics, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health, having authored 469 papers that have together received 28.9k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (197 papers), Lipid metabolism and disorders (146 papers), Genetic Associations and Epidemiology (55 papers), Blood Pressure and Hypertension Studies (23 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Epigenetics and DNA Methylation (16 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers) and Birth, Development, and Health (14 papers). The work is most often cited by research in Surgery (11.7k citations), Cardiology and Cardiovascular Medicine (5.5k citations), Endocrinology, Diabetes and Metabolism (3k citations), Genetics (4.2k citations) and Molecular Biology (3.3k citations). Daniel Gaudet has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Diane Brisson, Marie‐Claude Vohl, Jean Bergeron, John J.P. Kastelein, Claude Gagné, Evan A. Stein, Thomas Jay Hudson, Jean‐Pierre Després, Erik S. G. Stroes and Joel N. Hirschhorn. Their work appears in journals such as Journal of clinical lipidology, Atherosclerosis, Journal of the American College of Cardiology, New England Journal of Medicine and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact